PARTICIPATING COMPANIES

Companies participating at Biotech Showcase 2020

 
Country

Company

 
USA

10x Genomics

 
USA

20/20 GeneSystems, Inc.

 
 
Australia

360Biolabs

 
 
USA

3E Bioventures

 
 
United Kingdom

4BIO Capital

 
France

4P PHARMA

 
 
USA

5AM Ventures

 
 
USA

6 Dimensions Capital

 
USA

A6 Pharmaceuticals LLC

 
 
USA

Aagami, Inc.

 
 
USA

A-Alpha Bio

 
 
USA

Aberdeen Investment Management

 
 
USA

ABES Venture Partners

 
 
USA

Abimmune Biopharma

 
United Kingdom

Abzena Limited (Cambridge)

 
USA

Acasti Pharma

 
Singapore

Accelerate Technologies Pte Ltd

 
 
Canada

Accel-Rx Health Sciences Accelerato

 
Japan

AccuRna Inc

 
 
USA

Acepodia

 
 
USA

Aceras Partners

 
USA

Achelios Therapeutics

 
USA

Aciont Inc.

 
USA

Aclaris

 
France

ACTICOR BIOTECH

 
 
USA

Actinium Pharmaceuticals Inc

 
Belgium

ActoBio Therapeutics

 
USA

Acucela, Inc.

 
 
USA

Acuris Partners

 
Australia

AdAlta

 
 
Canada

Adapsyn Bioscience Inc.

 
USA

Adjuvance Technologies

 
 
USA

Adjuvant Partners

 
USA

ADRx Inc.

 
USA

Adze Biotechnology Inc

 
 
USA

Aegis Capital Corp.

 
 
Germany

aescuvest.eu

 
France

Affilogic

 
 
USA

Affinity Growth Advisors

 
 
Japan

Aflac Innovation Partners G.K.

 
USA

AGC Biologics

 
 
USA

Agent Capital

 
USA

Agenus

 
 
USA

AgeX Therapeutics, Inc.

 
 
USA

Agile Therapeutics

 
 
USA

Agilent Technologies Inc

 
 
Australia

Agilex Biolabs

 
 
Netherlands

Aglaia Oncology Funds

 
Spain

Ahead Therapeutics

 
 
Japan

AIBIOS Co Ltd

 
 
USA

AiM Medical Robotics

 
USA

AireHealth

 
 
USA

AIVITA Biomedical

 
Japan

Ajinomoto Co., Inc.

 
 
USA

Akadeum Life Sciences, Inc.

 
 
United Kingdom

Albion Capital

 
USA

Albumedix

 
 
USA

Alcami

 
 
USA

ALEON PHARMA INTERNATIONAL

 
 
USA

Alignment Ventures

 
 
USA

Alira Health

 
 
USA

Allele Capital Partners, LLC

 
USA

Allen Institute

 
 
USA

AllerGenis

 
USA

Alliance for Cancer Gene Therapy

 
 
USA

Alliance for Regenerative Medicine

 
USA

Alloy Therapeutics

 
USA

Alnylam

 
Canada

Alpha Cancer Technologies

 
 
Israel

Alpha Tau Medical Ltd.

 
 
USA

AlphaSense, Inc.

 
 
USA

Alpine BioVentures GP LLC

 
United Kingdom

ALS:Rx

 
 
Spain

Alta Life Sciences

 
USA

Alteogen Inc.

 
USA

Altis Biosystems, Inc.

 
 
USA

AltPep Corporation

 
 
USA

AltrixBio

 
France

ALZPROTECT PHARMA

 
 
USA

American Business TV

 
USA

Amivas LLC

 
 
Canada

AmorChem

 
Netherlands

Amphera BV

 
 
USA

Amplity Health

 
 
USA

AMRI

 
Japan

Anaeropharma Science

 
USA

Anchiano Therapeutics

 
Japan

AnGes, Inc.

 
 
USA

Angex Pharmaceutical Inc

 
USA

Angiex Inc

 
 
United Kingdom

Angle Plc

 
 
China

AnHeart Therapeutics (Hangzhou) Co.

 
 
USA

Anima Biotech Inc

 
 
USA

Anixa Biosciences, Inc.

 
 
Sweden

Anocca AB

 
 
USA

Anokion

 
 
USA

ANP Technologies Inc

 
Denmark

Antag Therapeutics

 
Canada

Antibe Therapeutics Inc

 
 
USA

Antiva Biosciences

 
 
Austria

Apeiron Cell Therapies GmbH (ACellT)

 
 
United Kingdom

Apex Healthcare Consulting

 
USA

Apollo Life Science Partners

 
 
Germany

Apollo Ventures

 
Israel

Aposense

 
 
USA

Aptose Biosciences

 
 
USA

Aqua Partners LLC

 
 
USA

Aqualung Therapeutics, Corp

 
USA

Aquestive Therapeutics, Inc.

 
 
Hungary

Aquincum Incubator

 
 
USA

Arch Therapeutics

 
USA

Arena Pharmaceuticals

 
 
Germany

ARGO Publishing GmbH

 
 
USA

Aristea Therapeutics, Inc.

 
USA

Arizona Bioindustry Association, In

 
 
USA

Arizona Tech Investors

 
 
USA

Arkitekt Ventures

 
 
United Kingdom

Arrowfield Capital

 
USA

ARTham Therapeutics

 
Japan

ARTham Therapeutics Inc.

 
 
USA

Asahi Kasei

 
 
USA

Asahi Kasei America Inc

 
USA

Ascendia Pharmaceuticals

 
 
USA

Ascendiant Capital Fund LP

 
USA

ASDERA LLC

 
 
Belgium

ASIT Biotech

 
 
France

Asklepios Advisors

 
Japan

Astellas Pharma Inc

 
 
USA

Astellas Rx

 
 
USA

Astia Angels

 
 
Sweden

AstraZenenca

 
USA

Astrocyte Pharmaceuticals

 
USA

ATAI Life Sciences

 
 
USA

Ataia Medical

 
 
USA

ATCC

 
United Kingdom

Atelix Ltd

 
 
USA

Atheneos Ventures, LLC

 
 
United Kingdom

Atlantic Healthcare plc

 
 
USA

Atomwise

 
 
Germany

Atriva Therapeutics GmbH

 
 
USA

AuGC Partners

 
 
USA

AuntMinnie.com

 
USA

Auransa Inc

 
India

Aurigene Discovery Technologies Ltd

 
 
Japan

Aurora Partners K.K.

 
 
USA

Australian Consulate-General

 
United Kingdom

Avacta Life Sciences

 
 
USA

Avalon GloboCare

 
USA

Avammune Therapeutics Inc

 
 
Australia

Avance Clinical Pty Ltd

 
 
Ireland

Avectas Ltd

 
USA

Avisa Pharma

 
USA

AVM Biotechnology

 
 
USA

AvroBio

 
 
Canada

Axiom Real-Time Metrics

 
 
USA

AzurRx BioPharma

 
 
USA

Bachem Americas Inc

 
 
USA

Back Bay Life Science Advisors

 
 
USA

Baker McKenzie

 
France

BALMES TRANSPLANTATION

 
 
USA

Barbara Ryan Advisors

 
United Kingdom

Barrington James

 
USA

Bastion Biologics

 
 
Germany

Bayer AG

 
 
Switzerland

Bayer Consumer Care AG

 
USA

Bayer Healthcare LLC

 
USA

Baylor College of Medicine

 
USA

Baylor Scott & White Research Institute

 
 
USA

BBA

 
 
USA

BDO

 
Germany

Beoro Therapeutics GmbH

 
USA

Beroni Group

 
 
Australia

Beroni Group Limited

 
Italy

BetaGlue Technologies SpA

 
 
Japan

Beyond Next Ventures

 
 
USA

Big43Bio

 
 
USA

BIMA Capital, LLC

 
 
USA

BIO

 
 
India

Bio Ideations LLP

 
 
Australia

Bioasis Technologies, Inc.

 
 
USA

Biobridge Global

 
 
Australia

BioCapital Impact Fund

 
USA

Biocom

 
USA

Biodesy Inc

 
 
USA

BioFactura Inc

 
 
Netherlands

Biogeneration Ventures

 
USA

BioGraphene Inc.

 
 
USA

BioHealth Innovation

 
Denmark

Bioiinovation Institute

 
USA

BioIncept, LLC

 
 
Sweden

BioInvent International AB

 
 
USA

Bioinvest

 
Spain

Biokit Research & Development S L U

 
Canada

Biolab Pharma

 
 
Lithuania

Biomapas

 
 
USA

BioMarker Strategies, LLC

 
 
Switzerland

BioMedPartners AG

 
France

Biomunex Pharmaceuticals

 
 
USA

BioNJ Inc

 
Australia

Bionomics Ltd

 
South Korea

Bionoxx

 
 
South Korea

Bionoxx Inc.

 
 
Germany

BioNTech SE

 
 
Spain

Bionure Farma

 
 
United Kingdom

BioPartner UK

 
 
USA

BioPharma Global Inc.

 
France

BIOPHYTIS

 
 
Belgium

Bioqube Ventures

 
 
USA

BioQuest

 
 
USA

BioSense Global LLC

 
China

Biosion Inc.

 
USA

Biospecifics Tech Corp

 
 
USA

Biospherics.net

 
USA

BioSuperior Technology

 
Canada

BIOTECanada

 
 
France

Biotech Finances

 
 
USA

Biotech Investment Group

 
 
Switzerland

Biotechgate

 
China

Bio-Thera Solutions

 
 
USA

BioValleyCHINA Ventures

 
Switzerland

BioVersys AG

 
 
USA

BioWorld

 
Brazil

Biozeus Biopharmaceutical S.A.

 
Germany

BLAC-BioPharma UG

 
United Kingdom

Black Belt Tx

 
USA

Black Diamond Therapeutics

 
 
USA

BLinc Advisory

 
 
South Korea

Bluepoint Partners

 
USA

BlueWillow Biologics, Inc.

 
 
Israel

Body Vision Medical

 
 
USA

Boehringer Ingelheim Biopharmaceuticals GmbH

 
China

Boehringer Ingelheim International Trade (Shanghai) Co., Ltd.

 
 
China

BOHE Angel Fund

 
United Kingdom

Bold Health

 
 
Germany

Boltendahl International Partners

 
 
Netherlands

BOM Capital II B.V.

 
Japan

Bonac Corporation

 
Belgium

Bone Therapeutics

 
South Korea

Boryung biopharma

 
South Korea

Boryung Pharmaceutical Co Ltd

 
 
USA

Boston Healthcare Associates

 
 
France

Bpifrance Investissement

 
 
USA

Brace Pharma Capital

 
 
USA

Brain Trust Bio

 
 
USA

Brainstorm Cell Therapeutics

 
USA

BrainTrust Bio

 
 
USA

Brandon Capital Partners

 
 
USA

Brex Inc

 
 
USA

BriaCell Therapeutics Corp

 
 
USA

Bridge Valley Ventures

 
USA

BridgeBio Pharma

 
 
USA

Bridle Path Investments Inc.

 
China

Briiliant Pharma

 
 
USA

Broadview Ventures

 
 
USA

Brookline Capital Markets

 
 
USA

BryoLogyx Inc

 
USA

Business France

 
USA

Buto Corporation

 
USA

BW Therapeutics

 
 
USA

C&EN

 
 
USA

C14 Consulting Group LLC

 
 
USA

C3 Research Associates

 
 
USA

Caladrius Biosciences, Inc.

 
 
USA

California Israel Chamber Of Commer

 
 
USA

California Life Sciences Association

 
USA

California Life Sciences Institute

 
 
USA

Camargo

 
 
Canada

Camargo Pharmaceutical Services

 
 
United Kingdom

Cambridge Innovation Capital

 
Australia

Cancer Trials Australia

 
United Kingdom

Capella Bioscience

 
USA

Capellla Therapeutics, Inc.

 
 
United Kingdom

Capital International Limited

 
 
Canada

Caprion Biosciences Inc

 
Germany

Captain T Cell

 
Switzerland

Captor Therapeutics

 
France

Cardio Renal

 
France

Cardiologs

 
USA

Caribou Biosciences, Inc

 
 
USA

Carmell Therapeutics

 
France

CarThera

 
USA

CASI Pharmaceuticals Inc

 
 
USA

Catalent, Inc.

 
 
USA

Cato Research

 
USA

CATX Inc

 
 
China

CD Capital

 
USA

Celata Therapeutics

 
USA

Celavie Biosciences, LLC

 
United Kingdom

Cell and Gene Therapy Catapult

 
USA

Cell Care Therapeutics

 
 
USA

Cellectar Biosciences Inc

 
Singapore

Celligenics Pte Ltd

 
Portugal

CellmAbs SA

 
USA

Cello Health BioConsulting

 
 
USA

Center for Innovative Technology

 
Switzerland

Cerbios-Pharma SA

 
 
Sweden

Cereno Scientific

 
 
USA

Certara

 
 
USA

CG Life

 
 
USA

Chaperone Investment

 
 
USA

Chemical & Engineering News

 
 
USA

ChemioCare

 
China

Chengdu Baiyu Pharmaceutical Co

 
Italy

Chiesi Farmaceutical Spa

 
 
China

ChinaBio Group

 
United Kingdom

Chronos therapeutics

 
USA

Chronus Health

 
France

Cilcare

 
United Kingdom

CIMYM BioSciences

 
 
USA

CincyTech

 
 
USA

Cipla New Ventures

 
USA

Cision Vision

 
 
United Kingdom

Citigate Dewe Rogerson

 
Netherlands

Citryll B.V.

 
South Korea

CJ HealthCare

 
 
USA

Clarigent Health

 
 
USA

Class Bravo Ventures

 
 
USA

ClearView Healthcare Partners

 
 
USA

Cleveland Clinic Ventures

 
 
United Kingdom

Clinical Accelerator

 
 
USA

Clinical Network Services Pty. Ltd.

 
 
Singapore

Clinical Research Ventures

 
 
USA

Close Concerns

 
United Kingdom

Closed Loop Medicine Ltd

 
 
USA

ClostraBio

 
 
USA

CM Capital Corporation

 
 
China

CMAB Biopharma

 
 
Australia

CMAX Clinical Research

 
 
Japan

CMIC HOLDINGS Co Ltd

 
United Kingdom

CN Bio Innovations Ltd

 
 
USA

Cofactor Genomics

 
 
USA

Cognoptix

 
 
USA

Connecticut Innovations

 
 
USA

Consulate General of Lithuania

 
 
USA

Consulate of Canada

 
 
USA

Consulate of the Netherlands

 
 
USA

Content Carnivores, LLC

 
 
USA

Context Therapeutics

 
 
USA

ContraFect Corporation

 
 
USA

Convalesce

 
 
USA

Conway Communications

 
South Korea

Corestem

 
 
USA

Corporate Fuel Partners

 
 
Australia

CoSec Consulting

 
 
United Kingdom

Coulter Partners

 
 
USA

Covance

 
 
USA

Cove Fund II

 
 
USA

Covington & Burling LLP

 
 
China

Cowin Venture

 
 
USA

CPC Scientific Inc

 
 
USA

CranioSense LLC

 
 
USA

CRB

 
USA

Creatv MicroTech, Inc.

 
 
Netherlands

Cristal Therapeutics

 
 
USA

Cryoport

 
South Korea

CrystalGenomics, Inc.

 
 
USA

CTD Holdings Inc

 
USA

CTI

 
 
USA

CTI Facts

 
 
Canada

CTI Life Sciences Fund

 
 
USA

Cultivation Capital

 
 
USA

CuRAGE Therapeutics

 
United Kingdom

CV6 Therapeutics, Inc.

 
 
USA

CVI Pharmaceuticals

 
 
USA

Cybernaut Zfounder Venture

 
 
USA

Cyclacel Pharmaceuticals, Inc.

 
 
USA

CytoDyn Inc.

 
 
USA

CytoSorbents Corporation

 
USA

Cytovia Therapeutics

 
France

Da Volterra

 
South Korea

Daewoong Bio

 
South Korea

Daewoong Pharmaceutical

 
 
Norway

Dagens Næringsliv

 
USA

Daiichi Sankyo

 
USA

Dale Biotech, LLC

 
 
USA

DavosPharma

 
 
South Korea

DAYLI Partners

 
 
Switzerland

Debiopharm Innovation Fund SA

 
 
Switzerland

Debiopharm International SA

 
 
China

Decheng Capital

 
 
USA

DeckTherapeutics Inc.

 
USA

Decoy Biosystems, Inc.

 
 
USA

DEFTA Partners

 
USA

DEL BioPharma

 
 
China

Delian Capital

 
 
Hong Kong

Delos Capital

 
Austria

Delta 4

 
 
USA

Demy-Colton

 
 
United Kingdom

Destiny Pharma plc

 
 
China

Deyi Capital Management

 
 
USA

DFA Consulting

 
 
USA

DFB Pharmaceuticals LLC

 
 
USA

DHVC

 
France

Diabeloop

 
USA

Diapin Therapeutics

 
USA

DigiTx Partners

 
Australia

Dimerix Ltd

 
 
USA

Dipharma Inc

 
USA

Diverse Biotech

 
 
Canada

Diversigen

 
USA

DNALite Therapeutics

 
 
Sweden

DNB Markets

 
 
USA

Dogtown Media

 
 
USA

Dolby Family Ventures

 
 
France

Domain Therapeutics

 
South Korea

Dong-A ST

 
 
USA

Dorset Capital LLC

 
Singapore

DotBio

 
USA

Drexel University

 
USA

DrugCendR Inc.

 
USA

Drusolv Therapeutics

 
 
USA

DSI

 
USA

DTx Pharma

 
USA

Dualogics

 
USA

DuPont

 
 
USA

Durbin Global

 
 
USA

Dyadic International Inc

 
Japan

DyDo Pharma Inc

 
 
United Kingdom

Dynamic Metrics

 
 
USA

Dynamk Capital

 
Japan

EA Pharma Co Ltd

 
 
Switzerland

Earlybird

 
USA

EarlyDiagnostics, Inc

 
 
USA

Easton Capital Investment Group

 
 
USA

EBD Group

 
USA

Eccrine Systems, Inc.

 
USA

Edesa Biotech, Inc

 
United Kingdom

Edinburgh Molecular Imaging

 
 
USA

Edison Group

 
 
USA

Edison Investment Research

 
Japan

EditForce, Inc.

 
 
Puerto Rico

EGB Ventures

 
 
China

Eight Roads Ventures

 
 
Japan

Eight Roads Ventures Japan

 
 
Denmark

Eir Ventures

 
 
Germany

Eisbach Bio GmbH

 
 
USA

EisnerAmper

 
USA

Elanco

 
United Kingdom

Elasmogen Ltd

 
USA

Eleusis

 
 
USA

Elex Biotech

 
 
USA

Eloxx Pharmaceuticals

 
France

ELSE CARE

 
 
USA

EMD Serono

 
 
USA

Emerald Bioscience, Inc

 
 
USA

Emerald Development Managers LP

 
USA

Emerald Health Pharmaceuticals Inc.

 
 
USA

Emerson Collective

 
USA

Enable Injections

 
 
USA

ENB Therapeutics

 
 
USA

EnePharma Inc.

 
 
Australia

EnGeneIC Ltd

 
 
USA

Engine Room

 
 
United Kingdom

Engitix Limited

 
USA

Enteris BioPharma

 
 
South Korea

Enzychem Lifesciences Corp

 
 
USA

Enzyvant

 
USA

EOC Pharma

 
Belgium

EPICS Therapeutics

 
 
United Kingdom

Epidarex Capital

 
 
USA

EpiVax Oncology, Inc.

 
 
Japan

e-Projection K.K.

 
Hong Kong

Epygenix

 
USA

Epygenix Therapeutics, Inc.

 
 
United Kingdom

ERA Consulting UK lTD

 
USA

Erytech Pharma

 
 
Singapore

Esco Ventures X

 
 
United Kingdom

Esperante

 
Germany

Eternygen GmbH

 
 
Germany

Ethris GmbH

 
South Korea

EuBiologics Co., Ltd.

 
 
Belgium

EuropaBio

 
 
USA

Evaluate

 
USA

Evecxia Inc

 
 
USA

Evolution Life Science Partners

 
USA

Evotec

 
United Kingdom

Evotec UK Limited

 
United Kingdom

Evox Therapeutics Ltd

 
USA

Extend Biosciences

 
 
USA

EXXclaim Capital

 
Netherlands

Facio Therapies

 
USA

Fannin Partners LLC

 
 
China

Fapon Capital Inc.

 
 
Hungary

FastVentures

 
 
China

FC Capital

 
Canada

Feldan Therapeutics

 
USA

Felicitex Therapeutics, Inc.

 
USA

Felix Biotechnology, Inc.

 
 
USA

Ferghana Partners Inc

 
Switzerland

Ferring Pharmaceuticals

 
USA

Ferring Research Institute Inc

 
 
Germany

FGK Clinical Research GmbH

 
 
Canada

Field Trip Health Inc.

 
France

FineHeart

 
USA

Firstlight Pharmaceuticals

 
 
USA

Flow Pharma, Inc.

 
 
USA

FMG Ventures

 
 
USA

Foley Hoag

 
 
USA

Foley Hoag LLP

 
 
Netherlands

Forbion

 
USA

Forcyte Biotechnologies

 
Finland

Forendo Pharma Ltd.

 
 
Taiwan

ForMED Ventures Ltd

 
 
USA

Fortunatus Capital

 
 
USA

ForwardVue Pharma

 
Switzerland

Fosun Pharmaceutical AG

 
 
USA

Foundation BioVentures

 
 
Ireland

Fountain Healthcare Partners

 
 
USA

FoxHill Asset Management

 
 
USA

FRAXA Research Foundation

 
 
USA

Fred Hutch

 
 
USA

Freelancer

 
 
USA

Fresh Venture Development

 
 
Canada

FSD Pharma, Inc

 
 
USA

FUJIFILM Diosynth Biotechnologies USA

 
 
Belgium

Fund+ NV

 
South Korea

G+FLAS Life Sciences, inc.

 
 
USA

G4S Capital

 
USA

Galenus Therapeutics Inc.

 
 
USA

Galileo Biosystems, Inc.

 
Israel

Gals Bio Ltd

 
 
Austria

GBA Group Pharma

 
South Korea

GC Pharma

 
 
USA

Geistlich Pharma

 
USA

Geistlich Pharma NA

 
USA

Gemseki Inc

 
USA

GenCure

 
USA

Gene To Be

 
USA

GeneLancet Biosciences, Inc

 
 
South Korea

Generoath

 
 
Canada

Genesys Capital

 
 
Australia

Genetic Technologies

 
Switzerland

GeNeuro SA

 
 
USA

Genevant Sciences Inc.

 
Netherlands

Genmab

 
France

Genoscience Pharma

 
 
USA

Genprex, Inc.

 
USA

GeoVax Labs, Inc.

 
USA

Geron Corporation

 
 
United Kingdom

GHO Capital Partners

 
South Korea

GI INNOVATION

 
 
Netherlands

Gilde Healthcare Partners

 
 
Germany

Gimv

 
Belgium

Gimv NV

 
France

GIP GENOPOLE

 
 
China

GL Capital

 
 
USA

GLAdiator Biosciences

 
 
USA

Glickman Family Office

 
 
USA

Global Alpha Ventures

 
 
Canada

Global Connectworks Ltd

 
 
USA

Global Source Ventures LLC

 
 
USA

GlobalData

 
 
USA

GlobalData Healthcare

 
Netherlands

Glycostem Therapeutics B.V.

 
 
Canada

Glysantis Inc.

 
 
USA

Good Health Capital NY

 
 
USA

Gore Range Capital

 
 
USA

GPG Ventures

 
 
China

Gracell Biotechnologies

 
 
USA

Gray Strategic Advisors, LLC

 
 
USA

Great Point Partners Llc

 
 
USA

Green Park & Golf Ventures

 
 
USA

Greenberg Traurig

 
 
Italy

GreenBone Ortho

 
 
USA

GreenField Chemical, Inc.

 
 
Australia

GreenLight Clinical

 
 
Canada

GreenSky Capital

 
USA

Greenwich Biosciences, Inc.

 
 
USA

Grey Sky Venture Partners

 
Germany

Grunenthal GmbH

 
USA

GSK Consumer Healthcare

 
 
USA

GSR Ventures

 
 
United Kingdom

GTJA Investment Group

 
Russian Fed.

Gurus BioPharm LLC

 
 
USA

H.C. Wainwright & Co.

 
 
Norway

Hadean Ventures AS

 
 
South Korea

Haim bio Co., Ltd

 
China

Haisco Pharmaceutical Ltd

 
 
USA

Halloran Consulting Group

 
South Korea

Hanmi Pharm Co Ltd

 
 
USA

HatchBIo Fund

 
USA

Hava Health Inc.

 
USA

Hawaii Biotech

 
 
Puerto Rico

HAYIM Group

 
USA

Healios

 
 
Japan

HEALIOS K.K.

 
USA

HealthBeacon

 
 
USA

Healthy and Sustainable Foods

 
 
USA

Healx

 
 
United Kingdom

Healx Limited

 
 
Japan

Heartseed Inc.

 
USA

Heat Biologics

 
 
USA

Helicase Venture

 
 
Canada

Helix BioPharma Corp

 
 
USA

Helix Ventures

 
 
Monaco

Helsinn

 
USA

HemoGenyx LLC

 
China

Henlius Biotech, Inc.

 
USA

Hepion Pharmaceuticals, Inc.

 
 
USA

HepQuant

 
Germany

Heraeus Holding GmbH

 
Germany

Heraeus Medical GmbH

 
 
USA

Hercules Capital

 
 
Singapore

Heritas Capital Management

 
 
Monaco

Hestia Investments Ltd.

 
 
China

Hexaell Biotech

 
 
Germany

High-Tech Gruenderfonds

 
USA

Hillstream BioPharma Inc.

 
China

HitGen Inc.

 
 
China

HJB CDMO

 
USA

HMS Life Science Advisory

 
USA

Hogan Lovells

 
 
USA

Hongjing Capital

 
 
USA

Honorary Consulate of Belgium - San

 
Canada

Hop-Child Technologies. inc.

 
 
Hong Kong

Horizons Ventures

 
USA

Houston Methodist

 
Australia

Hudson Institute of Medical Researc

 
USA

HUYA Bioscience International LLC

 
 
South Korea

Hyun & Partners Korea

 
USA

IACTA Pharmaceuticals, Inc.

 
 
United Kingdom

IAG

 
 
USA

Iaso Ventures

 
Russian Fed.

Ibraco, LLC

 
 
USA

ICON plc

 
 
USA

ICT

 
USA

IDBiologics

 
 
United Kingdom

IGEM Therapeutics Ltd

 
 
USA

IGF Oncology LLC

 
France

IKTOS

 
South Korea

ILIAS Biologics

 
 
USA

Illingworth Research Group

 
 
USA

Illumina Ventures

 
 
Canada

IMAGIA

 
USA

Immix Biopharma

 
Canada

Immune Biosolutions

 
South Korea

ImmuneMed, Inc.

 
 
USA

Immunexpress

 
Israel

Immunity Pharma

 
Israel

Immunity Pharma Ltd.

 
 
USA

ImmunoMet Therapeutics

 
USA

Immunova

 
 
United Kingdom

Immupharma Plc

 
 
USA

Immuron Limited

 
 
USA

Immutep

 
Australia

Imugene Limited

 
 
USA

Incysus Therapeutics, Inc.

 
 
Italy

Indaco Venture Partners SGR

 
 
USA

Indalo Therapeutics

 
Italy

Indena SpA

 
USA

Inexos Therapeutics

 
 
USA

Infervision U.S.

 
USA

Inflammatory Response Research, Inc.

 
France

Inflectis Bioscience

 
 
USA

Informa

 
 
United Kingdom

InHealth Ventures

 
Denmark

Initiator Pharma

 
 
Netherlands

Inkef Capital BV

 
 
Canada

InMed Pharmacauticals Inc.

 
 
Italy

Innogest Capital

 
 
USA

Innovative Cellular Therapeutics

 
 
Germany

INOGROUP

 
Switzerland

Inositec AG

 
 
USA

Inovation Ventures

 
 
USA

Inovio Pharmaceuticals

 
 
Denmark

InProTher ApS

 
 
Hong Kong

Insilico Medicine

 
France

Institut de Recherches Servier

 
 
USA

Interlaken Associates

 
Netherlands

InteRNA Technologies BV

 
USA

Interpace Diagnostics

 
United Kingdom

Intract Pharma Limited

 
 
Canada

Intrinsik Health Sciences Inc

 
 
USA

Intrommune Therapeutics

 
USA

InveniAI Corporation

 
Canada

Inversago Pharma

 
 
Lithuania

Invest Lithuania

 
 
Canada

Investing News Network

 
 
Denmark

IO Biotech

 
USA

Iomx Therapeutics

 
 
Germany

iOmx Therapeutics AG

 
 
Amer.Virgin Is.

Ionic Ventures, LLC

 
 
Switzerland

IPF Partners

 
 
USA

IPSEN BioSciences

 
 
USA

Ipsos

 
Italy

IRBM SpA

 
 
USA

IRISYS LLC

 
Puerto Rico

Isla Pharmaceuticals

 
United Kingdom

Isogenica Ltd

 
USA

iVeena Delivery Systems INC

 
 
Japan

JAFCO Co Ltd

 
 
USA

JDRF T1D Fund

 
USA

Jefferson Health

 
 
China

Jiangsu Atom Bioscience and Pharmaceutical Co. Ltd.

 
 
Japan

Jiksak Bioengineering, Inc.

 
USA

Johns Hopkins Technology Ventures

 
 
USA

Johnson & Johnson

 
 
USA

Johnson Matthey PLC

 
China

Joincare Pharmaceutical Group

 
 
USA

Joyance Partners

 
 
USA

JP Morgan

 
USA

JT Pharma

 
 
India

Jubilant Biosys

 
India

Jubilant Life Sciences Ltd

 
 
USA

Jubilant Therapeutics Inc

 
 
USA

Julz Co LLC

 
 
USA

KAER Biotherapeutics

 
 
China

Kaitai Capital

 
Indonesia

Kalbe Genexine Biologics

 
 
United Kingdom

KaNDy Therapeutics

 
Spain

Kantar

 
USA

Kantar Health

 
 
USA

Kapor Capital

 
United Kingdom

Karus Therapeutics

 
USA

Karyopharm Therapeutics

 
USA

Katan Associates

 
 
Australia

Kazia Therapeutics Limited

 
 
USA

KBI Biopharma

 
 
USA

KBP Biosciences

 
 
USA

KCK Group

 
France

Keen Eye Technologies

 
USA

Keystone Bio

 
Japan

Kihara Memorial Yokohama Foundation

 
 
USA

Kineticos Life Sciences

 
 
USA

Kinexum

 
 
USA

Kingdom Capital

 
 
USA

Kingsford Capital Management

 
Canada

KisoJi Biotechnology

 
Israel

Kitov Pharma

 
 
USA

Kiyoizumi Advisory LLC

 
 
USA

Kleo Pharmaceuticals

 
 
USA

Koenig, Oelsner, Taylor, Schoe

 
USA

Kolon TissueGene

 
 
USA

Komodo Health

 
South Korea

Konyang University

 
USA

Kowa Research Institute Inc

 
Japan

Kyoto University

 
 
USA

Kyto Technology and Life Science, I

 
 
USA

Kytopen

 
USA

LA BioMed

 
 
USA

LabConnect, LLC

 
Spain

Laboratorios Rubio S. A.

 
 
Australia

Lachesis Biosciences Ltd

 
USA

Lactocore, Inc.

 
 
China

Laekna Therapeutics

 
 
USA

Lake Capital

 
USA

LambdaVision

 
 
USA

Landmark Angels/Family Office

 
USA

Landos Biopharma

 
 
USA

Lantern Pharma

 
USA

Lassogen, Inc.

 
 
USA

Latham Biopharm Group

 
 
USA

LaVoie HealthScience

 
 
Australia

LBT Innovations

 
USA

Leading BioSciences Inc

 
South Korea

LegoChem Biosciences

 
 
USA

Levine Media Group

 
USA

Lexicon Pharmaceuticals

 
South Korea

LG Chem

 
Canada

Life Chemicals Inc.

 
 
USA

Life Science Angels

 
 
USA

Life Science Washington

 
 
United Kingdom

LifeArc

 
 
USA

LifeSci Advisors

 
 
United Kingdom

LIfT BioSciences

 
 
USA

Light Line Medical, Inc.

 
 
USA

Lilly Asia Ventures

 
Portugal

Limm Therapeutics

 
 
USA

Lincoln Park Capital

 
 
USA

Lineage Cell Therapeutics

 
 
Australia

Linear Clinical Research

 
 
China

Lingmed

 
 
Japan

LINK-J

 
USA

Lipella Pharmaceuticals Inc

 
 
Sweden

Lipidor AB

 
France

LLTech

 
United Kingdom

Locate Bio Limited

 
 
Hong Kong

Longenesis

 
 
USA

Longevity Vision Investment Advisor

 
 
USA

Lonza

 
 
USA

Lowell Therapeutics, Inc.

 
 
USA

Lowenstein Sandler LLP

 
 
China

LoyalValley Capital

 
USA

LSU Health Sciences Center

 
 
USA

Lucy Therapeutics, Inc.

 
 
Australia

Luina Bio Pty Ltd

 
Canada

LumIR Lasers

 
 
Canada

Lumira Ventures

 
 
Denmark

Lundbeckfonden Emerge

 
China

Luoxin Biotechnology(Shanghai) Co.,

 
France

LXRepair

 
 
USA

LYFE Capital

 
 
USA

Lymo Ventures - Life Science Angels

 
France

Lyon Biopole

 
 
Netherlands

M Ventures BV

 
 
France

MaaT Pharma

 
 
USA

MabPlex USA Inc

 
 
USA

MacDougall

 
 
United Kingdom

Macrophage Pharma

 
USA

Magnolia Therapeutics

 
USA

MAIA Biotechnology Inc

 
 
USA

MaidStone Life Sciences

 
 
USA

Maple Leaf Partners

 
 
USA

Mariam Global Health LLLP

 
Japan

Maruho Co Ltd

 
 
USA

Maryland Life Sciences

 
 
USA

Massachusetts Biotechnology Council

 
USA

MatriSys Bioscience

 
 
USA

MaveriX Oncology Inc

 
 
USA

MBio Diagnostics

 
 
Japan

MBL Venture Capital Co., Ltd.

 
 
Germany

MC Services AG

 
Germany

MCG Motion Capture GmbH

 
USA

MD Anderson

 
 
South Korea

MD Healthcare Inc.

 
USA

MD2 Biosciences Inc

 
USA

Medexus Pharma, Inc.

 
 
USA

Medical Marketing Economics LLC

 
Canada

MEDICENNA Therapeutics

 
France

Medincell

 
 
South Korea

Medivate Partners

 
 
USA

Medmarc

 
 
USA

MedTech Innovator

 
France

Meersens

 
USA

Mekanistic Therapeutics, LLC

 
 
USA

Melior Pharmaceuticals

 
USA

Memgen

 
Switzerland

Memo Therapeutics AG

 
Netherlands

MercachemSyncom

 
USA

Merck

 
USA

Merck and Co

 
 
Germany

Merck Heathcare KGaA

 
USA

Merck KGaA

 
 
Singapore

Merck Pte Ltd

 
USA

Merck Sharp & Dohme Corp

 
 
USA

Mergermarket

 
 
USA

MergerMarket Acuris Group

 
 
USA

Mesa Verde Venture Partners

 
 
USA

Mesoblast

 
 
USA

Metacrine Inc

 
Japan

Metcela Inc.

 
South Korea

MetiMedi Phamaceuticals

 
Switzerland

Metys Pharmaceuticals

 
 
USA

Meyers Investments Family Lp

 
United Kingdom

MGB Biopharma

 
USA

MichBio

 
 
Japan

Microbialchem

 
 
United Kingdom

Microbiotica

 
USA

MicroCures Inc.

 
 
USA

Migraine.AI

 
 
Japan

Miibio,Inc.

 
 
Germany

Miltenyi Biotec

 
Denmark

MinervaX

 
 
USA

Ministry of Foreign Affairs

 
United Kingdom

MIP Diagnostics Ltd

 
United Kingdom

Mironid

 
 
USA

Mirror Biologics, Inc.

 
Singapore

Mirxes Pte Ltd

 
USA

Mitochon Pharmaceuticals

 
Luxembourg

Mitotech S.A.

 
USA

Mitsubishi Tanabe Pharma Corporatio

 
 
Japan

Mitsui Fudosan Co., LTD.

 
 
USA

Mitsui Global Investment

 
 
USA

Mizuho Securities USA LLC

 
 
Germany

MLM Medical Labs GmbH

 
 
United Kingdom

MMC Ventures

 
Japan

Mochida Pharmaceutical Co Ltd

 
 
USA

Moderna Therapeutics

 
 
Netherlands

Modra Pharmaceuticals BV

 
USA

Molecular Templates

 
 
United Kingdom

Momentum Biotech

 
Japan

Momotaro-Gene Inc

 
 
USA

Montgomery County Economic Developm

 
 
USA

Montrose capital Partners

 
 
USA

Moore Venture Partners

 
 
United Kingdom

Morgan Prestwich

 
 
China

Morningside Ventures

 
 
USA

MP Healthcare Venture Mgmt Inc

 
 
USA

MPM Capital

 
 
USA

MSQ Ventures

 
USA

Multimeric Biotherapeutics, Inc.

 
 
USA

MVP Capital Partners

 
Canada

My Intelligent Machines

 
France

MyBrain Technologies

 
 
USA

MyCancerDB

 
 
Japan

MycHunter Therapeutics

 
 
USA

Myeloid Therapeutics

 
 
USA

Naked Biome

 
 
USA

Nammi Therapeutics

 
China

Nanjing Bioheng Biotech Co., Ltd

 
United Kingdom

Nanomerics

 
 
Canada

Nanostics Inc

 
 
USA

NanoSurface Bio

 
 
USA

NanoView Biosciences

 
USA

Nashville Biosciences

 
USA

National Cancer Institute

 
USA

National Institute on Aging

 
 
USA

Nature Biotechnology

 
 
USA

Navega Therapeutics

 
USA

Navidea Biopharmaceuticals

 
USA

Navigen

 
 
USA

NCL Technology Ventures

 
 
Sweden

NDA Group

 
 
United Kingdom

Neem Biotech Ltd

 
 
USA

NeoImmuneTech

 
USA

NeoProgen

 
 
United Kingdom

NeRRe Therapeutics

 
 
South Korea

NetTargets

 
 
USA

NeuBase Therapeutics

 
Australia

Neuclone

 
 
USA

Neumentum

 
 
USA

Neuraptive Therapeutics, Inc

 
Canada

Neuro Solutions Group

 
USA

Neurocrine Biosciences

 
USA

Neurocycle Therapeutics

 
 
Canada

Neurolign Technologies Inc.

 
 
Australia

Neuroscience Trials Australia

 
 
USA

Neurotech Reports

 
Sweden

NeuroVive Pharmaceutical AB

 
USA

New Mexico Tech

 
 
USA

New Perspectives Inc

 
 
USA

New Science Ventures

 
 
USA

Newomics Inc.

 
 
Japan

Newton Biocapital

 
USA

NexImmune, Inc.

 
South Korea

Nextgen Bioscience

 
 
South Korea

NIBEC

 
 
USA

Nieuw Amsterdam Advisors

 
USA

NIH

 
United Kingdom

NIHR Clinical Research Network

 
Japan

Nobelpharma Co., Ltd.

 
 
USA

Noble Life Science Partners

 
 
Hong Kong

Nomura International HK Ltd

 
Germany

Nordmark Arzneimittel GmbH & Co. KG

 
 
USA

Northern Light Venture Capital

 
 
USA

NorthStar Medical Technologies

 
South Korea

Noul Co., Ltd.

 
 
Belgium

Novadip Biosciences

 
Switzerland

Novaremed AG

 
China

Novartis

 
 
United Kingdom

Novasecta Ltd

 
USA

Novian Health

 
 
Denmark

Novo Holdings A S

 
USA

Novo Nordisk

 
 
Australia

Novotech

 
 
USA

Novotech CRO

 
 
USA

NSIP LLC

 
 
Australia

Nucleus Network

 
 
Canada

Nucro-Technics

 
USA

Nuritas

 
 
Puerto Rico

Oasis Capital, LLC

 
 
Sweden

Oasmia Pharmaceutical AB

 
 
USA

Oberland Capital

 
 
USA

Oceaniq Capital

 
 
USA

Octane Bio

 
 
USA

OCV Partners

 
 
USA

Oisin Biotechnologies

 
 
Israel

Omnix Medical

 
USA

ONC Bio

 
 
USA

OncoCellMDx, Inc.

 
 
South Korea

Oncocross Co Ltd

 
France

Oncodesign

 
France

Oncomedics

 
USA

OncoSTING

 
USA

OncoSynergy, Inc.

 
 
Switzerland

Onelife Fund

 
USA

ONL Therapeutics, Inc.

 
 
USA

OptiKira, LLC

 
Canada

Optina Diagnostic

 
 
United Kingdom

Optum Ventures

 
 
USA

Opus Biotech Communications

 
United Kingdom

Orbit Discovery Ltd

 
 
USA

Oresund Capital LLC

 
Japan

OriCiro Genomics

 
 
Germany

Oryx GmbH & Co KG

 
France

Osivax

 
Japan

Otsuka Pharmaceutical Co Ltd

 
USA

Otsuka Pharmaceutical Factory

 
 
Canada

Ovensa Inc.

 
 
USA

Ovid Therapeutics Inc.

 
Russian Fed.

Ovoca Bio Plc

 
United Kingdom

Oxford BioMedica PLC

 
 
USA

Oxidien Pharmaceuticals

 
United Kingdom

Oxsonics Therapeutics

 
United Kingdom

OxStem Limited

 
Belgium

Oxurion NV

 
New Zealand

Pacific Edge Limited

 
 
USA

Pact & Partners Recruitments

 
 
USA

Pacylex Pharmaceuticals

 
USA

PainQx

 
 
USA

Panacea Venture

 
 
Italy

Panakes Partners

 
Denmark

Pancryos

 
 
USA

Pandect Bioventures

 
 
Canada

Pangaea Ventures

 
USA

Panorama Medicine

 
 
USA

Pappas Capital

 
 
USA

Paradromics

 
Finland

Paras Biopharmaceuticals Finland OY

 
 
USA

Particular Ventures

 
 
Canada

Partner International Inc.

 
 
USA

Partnering Insight

 
 
Australia

Patheon

 
United Kingdom

Pathfinder Medical

 
 
USA

Pathway Bioventures

 
 
USA

PBM Capital Group

 
Norway

PCI Biotech

 
 
USA

Peak One Investments, LLC

 
United Kingdom

Pebmond Assciociates Ltd

 
USA

PeproMene Bio

 
South Korea

Peptron Inc

 
France

Perha Pharmaceuticals

 
 
USA

Pfenex Inc

 
 
China

Phagelux Inc.

 
 
Austria

PhagoMed Biopharma GmbH

 
 
USA

Phanes Therapeutics Inc

 
 
South Korea

PharmAbcine Inc.

 
 
USA

PharmaCatalyst LLC

 
 
USA

Pharmadirections

 
 
China

PharmaDJ

 
France

Pharmaleads

 
 
USA

Pharmalicensing

 
USA

Phase Genomics, Inc.

 
 
USA

Phase Scientific International

 
USA

Philips Healthcare

 
 
USA

Phio Pharmaceuticals

 
 
USA

Photon Fund

 
 
USA

PhotonPharma, Inc

 
 
Canada

PI Financial Corp

 
USA

Pin Therapeutics

 
 
USA

Piper Jaffray & Co

 
 
USA

Piramal Pharma Inc

 
 
Spain

Pivotal

 
 
USA

Plus Therapeutics

 
 
USA

PLx Pharma

 
United Kingdom

Pneumagen Ltd

 
 
USA

PoC Capital LLC

 
 
Switzerland

Polyneuron Pharmaceuticals AG

 
 
USA

PolyPeptide Group

 
 
Switzerland

Polyphor AG

 
USA

POP Biotechnologies

 
South Korea

POSVAX CO., LTD

 
 
China

PPC

 
 
USA

PRA Health Sciences

 
Switzerland

Preci Health SA.

 
 
USA

PRECISION FOR MEDICINE

 
 
USA

Precision for Medicine, Oncology &

 
 
USA

Preclinical GPS

 
 
South Korea

Premier Partners LLC

 
Australia

Prescient Therapeutics

 
 
USA

Prevail Partners

 
 
Germany

Profil GmbH

 
 
USA

Profusa, Inc.

 
United Kingdom

Prokarium

 
 
USA

ProMed Partners, LP

 
 
USA

Promethean Endeavors

 
 
Belgium

Promethera Biosciences

 
 
Poland

Proteon Pharmaceuticals S.A.

 
 
USA

Proteus Venture Partners

 
 
USA

ProTrials Research Inc

 
France

Provepharm Life Solutions

 
USA

PTM Therapeutics

 
 
USA

Pullan Consulting

 
USA

Pyramid Biosciences, Inc

 
USA

Pytho LLC

 
USA

Q Therapeutics, Inc

 
 
Australia

QBiotics Group Ltd

 
 
USA

Qilu Puget Sound Biotherapeutics Co

 
 
USA

Qiming Venture Partners

 
Australia

QIMR Berghofer

 
France

Quantum Genomics

 
 
Australia

QUE Oncology